JD Supra

Navigating Shockwave Medical: Applicant Admitted Prior Art, Standing, and Obviousness

Shockwave Medical, Inc. (“Shockwave”) owns U.S. Patent No. 8,956,371 (“the ’371 patent”). This patent is directed to the treatment of atherosclerosis through intravascular lithotripsy (“IVL”). The ...
JD Supra

The Precedent: Applicant Admitted Prior Art Can Be Used to Fill Missing Claim Limitations in a § 103 Obviousness Analysis

Shockwave owns US Patent No. 8,956,371 (the “’371 patent”), which is directed to the treatment of atherosclerosis through intravascular lithotripsy. The claimed device is for a “typical over-the-wire ...
TCTMD

Shockwave Balloon vs. Atherectomy With Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial

Valve Performance of Self-Expanding vs. Balloon-Expandable TAVR in Patients with a Small Aortic Annulus: Five-Year Results From the OCEAN-TAVI Registry Receive the the latest news, research, and ...
The National Law Review

Navigating Shockwave Medical: Applicant Admitted Prior Art, Standing, and Obviousness

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
TCTMD

TCT 133: Shockwave Balloon or Atherectomy with Rotablation in Calcified Coronary Artery Lesions: Primary Results of the SONAR Trial.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...